International Journal of Hematology and Oncology 2019, Vol 29, Num 4 Page(s): 001-005
Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery

Sevil ERCETIN1, Ibrahim C. HAZNEDAROGLU2, Mevlut KURT3, Ibrahim K. ONAL3, Alper AKTAS4, Ozlem K. KURT5, Hakan GOKER2, Oktay OZDEMIR6, Serafettin KIRAZLI1, Huseyin C. FIRAT1

1Ankaferd Health Products Ltd, Istanbul, TURKEY
2Hacettepe University Facultyof Medicine, Department of Hematology, Ankara, TURKEY
3Turkiye Yuksek Ihtisas Education and Research Hospital, Department of Gastroenterology, Ankara, TURKEY
4Hacettepe University, Faculty of Dentistry, Department of Oral Surgery, Ankara, TURKEY
5Ataturk Chest Disease and Chest Surgery Education and Research Hospital, Department of Chest Diseases, Ankara, TURKEY
6Yorum Consultancy Limited Company, Istanbul, TURKEY

Keywords: Ankaferd Blood Stopper, Dentistry, Bleeding, Wound healing
The aim of this study was to assess retrospectively the hemostatic efficacy and safety of the topical use of Ankaferd Blood Stopper (ABS) in the setting of dental surgery. Following the approval from of the Local Research Ethics Committee ABS as a hemostatic agent in Dentistry, ABS was topically applied by homogeneously spraying to the 25 patients during dental interventions. Based on this retrospective evaluation; Tissue healing was evaluated at the 48th hour. The patients received 1 to 5 mL of ABS; the median dose was 2 mL. Bleeding stopped in median 1.8 seconds (1 to 3 seconds) in the first ABS application in 20 patients. Five patients needed a second dose of ABS; four of them were given 5 mL ABS totally. No patient had wound infection and the healing process appeared to be normal. ABS is useful for the local hemostasis and wound healing in periodontal surgeries.